Center for Continuing Education
About The Cleveland Clinic Center for Continuing Education | Call or Email Us | About The Cleveland Clinic
Live Cleveland Clinic CME Courses |  Regularly Scheduled Series (RSS) Registration | Regulary Scheduled Series (RSS) Schedule (pdf)
Disease Management Project Clinical Decisions Cases |  Hepatitis C Management |  Managing Problem Patients with Anti-TNF Inhibitors |  More
Medicine Today Series |  B Cell Series |  Emerging Therapies in Heart Disease Webcast Series |  More
Disease Management Project |  CCJM 1-Minute Consult |  Pharmacotherapy Update Newsletter |  Algorithms for the MICU |  More
Cleveland Clinic Foundation CME Home Contact Us Live CME Courses Online CME Topics Webcasts Online Medical Publications my CME Search Sitemap e-mail Newsletter

   Vol.IV, No.I
   January/February 2001

 Return to
 Pharmacotherapy
 Update Index

 

Allergic Reactions

Did You Know. . .

Although the incidence of allergic reactions to local anesthetics has decreased, they are still documented. Allergic reactions to local anesthetic agents may occur as a result of sensitivity to 1) either the ester or amide component, 2) the methylparaben used as a preservative in the multiple dose vials, or 3) the antioxidants used in some formulations. Allergic reactions may consist of cutaneous lesions, urticaria, edema, or anaphylactoid reactions.

See Table 1 for a comparison of local anesthetics.

Ester local anesthetics are associated with a higher incidence of allergic reactions due to one of their metabolites, para-amino benzoic acid (PABA). PABA is structurally similar to methylparaben. Amide local anesthetics do not undergo metabolism to PABA, and therefore hypersensitivity to amide local anesthetics is rare. Because of these possible hypersensitivity reactions, many manufacturers have reformulated some of their products to eliminate methylparaben. Some of these products include: Nesacaine-MPF, Lidocaine-MPF, Polocaine-MPF, and Sensorcaine-MPF. A ruling by the Food and Drug Administration mandated the removal of methylparaben from all local anesthetic dental cartridges. Antioxidants (sodium bisulfite, metabisulfite) are added to local anesthetic products that contain vasoconstrictors (epineprhine, levonordefrin) to prevent biodegradation by oxygen.

Some patients may also be allergic to sulfites, and for this reason antioxidants should be avoided. It may be difficult to determine the allergy of the patient and skin testing can be utilized.

It is rare that a patient would be allergic to both an ester and amide local anesthetic. However, the following guidelines may assist in selecting an appropriate local anesthetic.

Guidelines:

If the patient is allergic:
1. to ester local anesthetics, try an amide local anesthetic.
2. to amide local anesthetics, try an ester local anesthetic.
3. to methylparaben or is allergic to both amide and ester local anesthetics, try a MPF product.
4. to antioxidants or sulfite components, review the product ingredients with the Department of Pharmacy or Drug Information Center (4-6456).